[1]
M. Xia, B. Zhan, and H. Zhan, “Comparison of Financial and Operating Conditions of Companies in The Biomedical Industry Before and after COVID-19”, BCPBM, vol. 37, pp. 281–289, Feb. 2023, doi: 10.54691/bcpbm.v37i.3577.